258 related articles for article (PubMed ID: 14694522)
1. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription.
Stein H; Marafioti T; Foss HD; Laumen H; Hummel M; Anagnostopoulos I; Wirth T; Demel G; Falini B
Blood; 2001 Jan; 97(2):496-501. PubMed ID: 11154228
[TBL] [Abstract][Full Text] [Related]
3. Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas.
Sáez AI; Artiga MJ; Sánchez-Beato M; Sánchez-Verde L; García JF; Camacho FI; Franco R; Piris MA
Mod Pathol; 2002 Mar; 15(3):211-20. PubMed ID: 11904338
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of internal enhancer activity contributes to abnormally low immunoglobulin expression in the MedB-1 mediastinal B-cell lymphoma cell line.
Ritz O; Leithäuser F; Hasel C; Brüderlein S; Ushmorov A; Möller P; Wirth T
J Pathol; 2005 Feb; 205(3):336-48. PubMed ID: 15682441
[TBL] [Abstract][Full Text] [Related]
5. Alterations of loci encoding PU.1, BOB1, and OCT2 transcription regulators do not correlate with their suppressed expression in Hodgkin lymphoma.
Cavazzini F; De Wolf-Peeters C; Wlodarska I
Cancer Genet Cytogenet; 2005 Apr; 158(2):167-71. PubMed ID: 15796964
[TBL] [Abstract][Full Text] [Related]
6. Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease.
Jundt F; Kley K; Anagnostopoulos I; Schulze Pröbsting K; Greiner A; Mathas S; Scheidereit C; Wirth T; Stein H; Dörken B
Blood; 2002 Apr; 99(8):3060-2. PubMed ID: 11929801
[TBL] [Abstract][Full Text] [Related]
7. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
[TBL] [Abstract][Full Text] [Related]
8. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma.
Hertel CB; Zhou XG; Hamilton-Dutoit SJ; Junker S
Oncogene; 2002 Jul; 21(32):4908-20. PubMed ID: 12118370
[TBL] [Abstract][Full Text] [Related]
9. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.
Arguello M; Sgarbanti M; Hernandez E; Mamane Y; Sharma S; Servant M; Lin R; Hiscott J
Oncogene; 2003 Feb; 22(7):964-73. PubMed ID: 12592383
[TBL] [Abstract][Full Text] [Related]
10. Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells.
Theil J; Laumen H; Marafioti T; Hummel M; Lenz G; Wirth T; Stein H
Blood; 2001 May; 97(10):3191-6. PubMed ID: 11342448
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma.
Ushmorov A; Leithäuser F; Sakk O; Weinhaüsel A; Popov SW; Möller P; Wirth T
Blood; 2006 Mar; 107(6):2493-500. PubMed ID: 16304050
[TBL] [Abstract][Full Text] [Related]
12. The BOB.1 / OBF.1 co-activator is essential for octamer-dependent transcription in B cells.
Laumen H; Nielsen PJ; Wirth T
Eur J Immunol; 2000 Feb; 30(2):458-69. PubMed ID: 10671201
[TBL] [Abstract][Full Text] [Related]
13. Btk expression is controlled by Oct and BOB.1/OBF.1.
Brunner C; Wirth T
Nucleic Acids Res; 2006; 34(6):1807-15. PubMed ID: 16582106
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas.
Greiner A; Müller KB; Hess J; Pfeffer K; Müller-Hermelink HK; Wirth T
Am J Pathol; 2000 Feb; 156(2):501-7. PubMed ID: 10666379
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression.
Ushmorov A; Ritz O; Hummel M; Leithäuser F; Möller P; Stein H; Wirth T
Blood; 2004 Nov; 104(10):3326-34. PubMed ID: 15284123
[TBL] [Abstract][Full Text] [Related]
16. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Moore EM; Swerdlow SH; Gibson SE
Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
[TBL] [Abstract][Full Text] [Related]
17. The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma.
Schneider EM; Torlakovic E; Stühler A; Diehl V; Tesch H; Giebel B
J Pathol; 2004 Dec; 204(5):538-45. PubMed ID: 15538755
[TBL] [Abstract][Full Text] [Related]
18. The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development.
Hess J; Nielsen PJ; Fischer KD; Bujard H; Wirth T
Mol Cell Biol; 2001 Mar; 21(5):1531-9. PubMed ID: 11238890
[TBL] [Abstract][Full Text] [Related]
19. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins.
Pileri SA; Gaidano G; Zinzani PL; Falini B; Gaulard P; Zucca E; Pieri F; Berra E; Sabattini E; Ascani S; Piccioli M; Johnson PW; Giardini R; Pescarmona E; Novero D; Piccaluga PP; Marafioti T; Alonso MA; Cavalli F
Am J Pathol; 2003 Jan; 162(1):243-53. PubMed ID: 12507907
[TBL] [Abstract][Full Text] [Related]
20. Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells.
Re D; Müschen M; Ahmadi T; Wickenhauser C; Staratschek-Jox A; Holtick U; Diehl V; Wolf J
Cancer Res; 2001 Mar; 61(5):2080-4. PubMed ID: 11280769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
